α-trinositol: A functional (non-receptor) neuropeptide Y antagonist in vasculature

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 1, 1996, Pages 77-84

  Sun, Xiangying ^a   You, Junping ^b   Hedner, Thomas ^b   Erlinge, David ^b   Fellström, Bengt ^c   Yoo, Heahyun ^d   Wahlestedt, Claes ^d   Edvinsson, Lars ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL 1,2,6 TRISPHOSPHATE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; ISOLATED ARTERY; MALE; NERVE STIMULATION; NONHUMAN; PRESSOR RESPONSE; RAT; SYMPATHETIC NERVE; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

EID: 0029923010     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05882.x     Document Type: Article

References (32)

1. Anderson, E. A., Sinkey, C. A., Lawton, W. J., Mark, A. L. (1989) Elevated sympathetic nerve activity in borderline hypertensive humans, evidence from direct intraneural recordings. Hypertension 14: 177-183
2. Berridge, M J., Irvine, R. F. (1989) Inositol phosphates and cell signalling. Nature 341: 197-205
3. Dahlöf, C., Dahlöf, P., Lundberg, J. M. (1985) Neuropeptide Y (NPY): enhancement of blood pressure increase upon α-adrenoceptor activation and direct pressor effects in pithed rats. Eur. J. Pharmacol. 109: 289-292
4. Edvinsson, L., Håkanson, R., Wahlestedt, C., Uddman, R. (1987) Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol. Sci. 8: 231-235
5. Edvinsson, L., Adamsson, M., Jansen, I. (1990) Neuropeptide antagonistic properties of D-myo-mositol-1,2,6-triphosphate in guinea pig basilar arteries Neuropeptides 17: 99-105
6. Edvinsson, L., Ekman, R., Thulin, T. (1991) Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man. Regul. Pept. 32: 279-287
7. Edvinsson, L., Erlinge, D., Sun, X. Y., Hedner, T. (1994) Neuropeptide Y in sympathetic co-transmission-recent advances in the search for neuropepude Y antagonists. Pharmacol. Toxicol. 74: 193-201
8. Kamm, K. E., Stull, J. T. (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann. Rev. Pharmacol. Toxicol. 25: 593-620
9. Larhammar, D., Blomqvist, A. G., Yee, F., Jaxin, E., Yoo, H., Wahlestedt, C. (1992) Cloning and functional expression of a human nruropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 267: 10935-10938
10. Lind, H., Brudin, L., Castenfors, J., Hedner, T., Lindholm L., Edvinsson, L. (1994) The effects of α-trinositol on haemodynamic variables and neuropeptide Y levels in a pilot study of hypertensives and healthy volunteers. Blood Pressure 3: 242-247
11. Lobaugh, L. A., Blackshear, P. J. (1990) Neuropeptide Y stimulation of myosin light chain phosphorylation in cultured aortic smooth muscle cell. J. Biol. Chem. 265: 18393-18399
12. Lundberg, J. M., Franco-Cereceda, A., Lacroix, J.-S., Pernow, J. (1990) Neuropeptide Y and sympathetic neurotransmission. Ann. NY Acad. Sci. 611: 166-174
13. Majerus, P. W., Ross, T. S., Cunningham, T. W., Caldwell, K. K., Jefferson, A. B., Banal, V. S. (1990) Recent insights in phosphatidylinostiol signalling. Cell 63: 459-465
14. 2+ increase in vascular smooth muscle cells. FEBS Lett. 259: 79-82
15. Pernow, J., Lundberg, J. M., Kaijser, L., Hjemdahl, P., Theodorsson-Norheim, E., Martinsson, A. (1986) Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin. Physiol. 6: 561-578
16. Pernow, J., Schwieler, J., Kahan, T., Hjemdahl, P., Oberle, J., Wallin, G. B , Lundberg, J. M (1989) Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release. Am. J. Physiol. 257: H866-H872
17. Putney, J. W. J. (1978) Stimulus-permeability coupling: role of calcium in the receptor regulation of membrane permeability. Pharmacol. Rev. 30: 209-245
18. Shears, S. B. (1989) Metabolism of the inositol phosphates produced upon receptor activation. Biochem. J. 260: 313-324
19. Stephens, L. R., Irvine, R. F. (1990) Stepwise phosphorylation of myo-inositol leading to myo-inositol hexakisphosphate in dictyostelium. Nature 346: 580-583
20. Stjärne, L., Lundberg, J. M., Åstrand, P. (1986) Neuropeptide Y - a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18: 151-166
21. Sun, X. Y., Dahlöf, C., Edvinsson, L., Hedner, T. (1991) D-myoinositol-1,2,6-trisphosphate (PP 56) is a selective antagonist of neuropeptide Y (NP Y) induced pressor response in the pithed rat. Eur. J. Pharmacol. 204: 281-286
22. Sun, X. Y., Edvinsson, L., Hedner, T. (1992) Effects of d-myoinositol-1,2,6-trisphosphate on neuropeptide Y induced potentiation of various vasoconstrictor agents in the rat. J. Pharmacol. Exp. Ther 261: 1147-1152
23. Sun, X. Y., Edvinsson, L., Hedner, T. (1993) Cardiovascular effects of α-trinositol in hypertensive (SHR) and normotensive (WKY) rats. J. Hypertension 11: 935-943
24. Sun, X. Y., Edvinsson, L., Yoo, H., Wahlestedt, C., Hedner, T. (1995) Effects of some novel D-myo-inositol phosphate derivatives on binding and sympathetic transmission. J. Cardiovasc. Pharmacol. 25: 696-704
25. Taddei, S., Salvetti, A., Pedrinelli, R. (1989) Persistence of sympathetic-mediated forearm vasoconstriction after α-blockade in hypertensive patients. Circulation 80: 485-490
26. Wahlestedt, C., Yanaihara, N., Håkanson, R. (1986) Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 13: 307-318
27. Wahlestedt, C., Håkanson, R., Vaz, C., Zukowska-Grojec, Z. (1990a) Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am. J. Physiol. 258: R736-R742
28. 1. Ann. NY Acad. Sci. 611:7-26
29. Wahlestedt, C., Reis, D. J., Edvinsson, L. (1991) A novel inositol phosphate acts as a selective neuropeptide Y (NPY) antagonist. Soc. Neurosci. 21: 11.6
30. 3) in rat tissues. Eur. J. Pharmacol. 268: 55-61
31. Zukowska-Grojec, Z., Wahlestedt, C. (1993) Origin and action of neuropeptide Y in the cardiovascular system. In: Colmers, W. F., Wahlestedt, C. (eds) The Neurobiology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, New Jersey, pp 315-388
32. Zukowska-Grojec, Z., Haass, M., Bayorh, M. (1986) Neuropeptide Y and peptide YY mediate non-adrenergic vasoconstriction and modulate sympathetic responses in rats. Regul. Pept. 15: 99-110